News

Filter

Current filters:

None

64 to 73 of 96672 results

Octapharma mulls building hemophilia product plant in Russia

27-10-2014

Independent Swiss biotech company Octapharma is considering building a plant for production of drugs…

BiotechnologyHematologyOctapharmaProductionRussia

Australian PBS listing for Kalydeco and Soliris

Australian PBS listing for Kalydeco and Soliris

27-10-2014

Kalydeco (ivacaftor) and Soliris (eculizumab) – new treatments for cystic fibrosis (CF) and hemolytic…

Alexion PharmaceuticalsAustraliaFinancialHealthcareKalydecoPharmaceuticalRare diseasesSolirisVertex Pharmaceuticals

Russian government to introduce state regulation of drug prices in domestic market

Russian government to introduce state regulation of drug prices in domestic market

27-10-2014

The Russian government is considering introducing state regulation of prices for drugs in the country,…

PharmaceuticalPoliticsPricingRussiaRussian government

Hikma shares slide as FDA issues warning letter over its Portugal injectables plant

Hikma shares slide as FDA issues warning letter over its Portugal injectables plant

27-10-2014

Jordanian drugmaker Hikma has seen its shares fall as a result of a warning from the US Food and Drug…

Hikma PharmaceuticalsHospiraPharmaceuticalPortugalRegulation

CTI acquires tosedostat rights from Vernalis and Chroma

CTI acquires tosedostat rights from Vernalis and Chroma

27-10-2014

Blood-related cancer specialist CTI BioPharma has acquired the worldwide rights to tosedostat through…

BiotechnologyChroma TherapeuticsCTI BioPharmaLicensingOncologytosedostatUSAVernalis

Calchan and Galapagos team up on osteoarthritic pain therapies

Calchan and Galapagos team up on osteoarthritic pain therapies

27-10-2014

UK-based Calchan Holdings, a company focused on developing medicines based on calcium ion channel modulators,…

Anti-Arthritics/RheumaticsCalchan HoldingsGalapagosResearchUK

CSL buys Novartis’ influenza vaccines business for $275 million

CSL buys Novartis’ influenza vaccines business for $275 million

27-10-2014

Swiss pharma major Novartis has agreed to divest its influenza vaccines business to Australia’s CSL…

Anti-viralsbioCSLCSL LimitedFinancialMergers & AcquisitionsNovartisPharmaceuticalVaccines

Bristol-Myers Squibb third-qtr earnings top expectations

Bristol-Myers Squibb third-qtr earnings top expectations

25-10-2014

US pharma major Bristol-Myers Squib posted a strong set of financials for the third quarter of 2014,…

Bristol-Myers SquibbFinancialPharmaceutical

FDA approves Baxter’s new treatment for rare form of hemophilia

FDA approves Baxter’s new treatment for rare form of hemophilia

25-10-2014

The US Food and Drug Administration on Friday approved Obizur (antihemophilic Factor [recombinant), porcine…

Baxter InternationalHematologyObizurPharmaceuticalRare diseasesUSA

64 to 73 of 96672 results

Parexel

Parexel

Back to top